Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
32
-
Total shares
-
4.59M
-
Shares change
-
+4.59M
-
Total reported value, excl. options
-
$45.8M
-
Value change
-
+$45.8M
-
Number of buys
-
32
-
Price
-
$10.00
Significant Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q1 2014
32 filings reported holding ARGS - ARGOS THERAPEUTICS INC - COM as of Q1 2014.
ARGOS THERAPEUTICS INC - COM (ARGS) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.59M shares
.
Largest 10 shareholders include WASATCH ADVISORS INC (1.24M shares), MARXE AUSTIN W & GREENHOUSE DAVID M (750K shares), CAISSE DE DEPOT ET PLACEMENT DU QUEBEC (744K shares), WALL STREET ASSOCIATES (518K shares), Pine River Capital Management L.P. (256K shares), ALTRINSIC GLOBAL ADVISORS LLC (250K shares), Alyeska Investment Group, L.P. (115K shares), VANGUARD GROUP INC (112K shares), BlackRock Fund Advisors (98.2K shares), and EDELMAN FINANCIAL GROUP INC. (74.4K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.